دورية أكاديمية

Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial

التفاصيل البيبلوغرافية
العنوان: Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial
المؤلفون: Mease, Philip J.Aff1, Aff2, IDs40744022004745_cor1, Kellner, Herbert, Morita, Akimichi, Kivitz, Alan J., Aslanyan, Stella, Padula, Steven J., Topp, Andrew S., Eldred, Ann, Behrens, Frank, Papp, Kim A.
المصدر: Rheumatology and Therapy. 9(5):1361-1375
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:21986576
21986584
DOI:10.1007/s40744-022-00474-5